Clinical Trials Logo

Clinical Trial Summary

This is a randomized, double-blinded, placebo-controlled dose-response efficacy study of oral (Z)-endoxifen in premenopausal women with measurable breast density. There will be 5 in-clinic visits (Screening, Day 1, Months 1, 3 and 6) and 3 self-report visits (Months 2, 4 and 5). Standard of care mammograms will be used for the screening mammogram as well as the 24-month follow up visit.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05068388
Study type Interventional
Source Atossa Genetics, Inc.
Contact Heather Fraser, PhD
Phone 206-707-3088
Email [email protected]
Status Not yet recruiting
Phase Phase 2
Start date November 8, 2021
Completion date December 31, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT03920098 - Association Between Maternal Metabolic Disturbances During the First Pregnancy and Breast Density
Completed NCT03029286 - ENGAGED 2 Study: Experiences With Mammography Screening and Breast Density 2 N/A